Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001509371 | SCV001716035 | uncertain significance | not provided | 2019-11-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001865960 | SCV002255507 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2022-10-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002568009 | SCV003526946 | uncertain significance | Inborn genetic diseases | 2023-04-03 | criteria provided, single submitter | clinical testing | Unlikely to be causative of SETX-related juvenile amyotrophic lateral sclerosis (AD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV001509371 | SCV003827522 | uncertain significance | not provided | 2021-09-01 | criteria provided, single submitter | clinical testing |